Anpario (LON:ANP) Trading Up 10.9% – Here’s Why

Shares of Anpario plc (LON:ANPGet Free Report) traded up 10.9% during mid-day trading on Friday . The company traded as high as GBX 415 ($5.07) and last traded at GBX 407.66 ($4.98). 152,837 shares were traded during trading, an increase of 273% from the average session volume of 40,994 shares. The stock had previously closed at GBX 367.50 ($4.49).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised their target price on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the company a “buy” rating in a research report on Wednesday, September 18th.

Check Out Our Latest Analysis on Anpario

Anpario Stock Up 10.9 %

The firm has a 50-day simple moving average of GBX 357.55 and a 200 day simple moving average of GBX 320.19. The stock has a market capitalization of £68.94 million, a P/E ratio of 2,264.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16.

Insider Buying and Selling

In other news, insider Karen Prior sold 14,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total transaction of £53,200 ($64,957.26). 30.51% of the stock is owned by corporate insiders.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.